Global Anatomic Pathology Testing Market 2017-2021

病理解剖検査の世界市場2017-2021

◆タイトル:Global Anatomic Pathology Testing Market 2017-2021
◆商品コード:IRTNTR12032
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年2月17日
◆ページ数:95
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,500 ⇒換算¥508,500見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、病理解剖検査の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、病理解剖検査の世界市場規模及び予測、用途別分析、製品別分析、需要先別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

・エグゼクティブサマリー
・病理解剖検査の世界市場:市場概観
・病理解剖検査の世界市場:業界の構造分析
・病理解剖検査の世界市場:市場規模及び予測
・病理解剖検査の世界市場:製品別分析
・病理解剖検査の世界市場:需要先別分析
・病理解剖検査の世界市場:用途別分析
・病理解剖検査の世界市場:地域別分析
・病理解剖検査の世界市場:アジア市場規模
・病理解剖検査の世界市場:アメリカ市場規模
・病理解剖検査の世界市場:ヨーロッパ市場規模
・病理解剖検査の世界市場:成長要因
・病理解剖検査の世界市場:課題
・病理解剖検査の世界市場:市場動向
・病理解剖検査の世界市場:競争状況
・病理解剖検査の世界市場:主要企業(ベンダー)分析
...

※上記の和訳は最新内容ではない場合があります。下記の英文概要・目次が最新版です。

About Anatomic Pathology Testing
The anatomic pathology testing helps in identifying abnormalities in tissue or cell lines and develops personalized care treatment. It helps to evaluate different types of cancers such as lung cancer, breast cancer, colorectal cancer, and chronic conditions such as kidney or liver disease, infectious disease, and autoimmune diseases.

Technavio’s analysts forecast the global anatomy pathology testing market to grow at a CAGR of 8.26% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global anatomy pathology testing market for 2017-2021. To calculate the market size, the report considers the revenue generated from anatomy pathology testing.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Anatomic Pathology Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Abbott Diagnostics
• Agilent Technologies
• Danaher
• Roche Diagnostics
• Thermo Fisher Scientific

[Other prominent vendors]
• 20/20 GeneSystems
• Abcam
• AdnaGen
• Advanced Cell Diagnostics
• Agendia
• Angsana Molecular & Diagnostics Laboratory
• AutoGenomics
• Biocare Medical
• Biocartis
• CellMax Life
• Cancer Genetics
• Digipath
• Enzo Biochem
• Epic Sciences
• Janssen Diagnostic
• Monogram Biosciences
• Nucleix
• Omnyx
• Oxford Cancer Biomarkers
• RareCyte
• SAKURA FINETEK USA
• Tecan
• VolitionRx

[Market driver]
• Growing prevalence of cancer in demographics
• For a full, detailed list, view our report

[Market challenge]
• High initial investment and maintenance costs
• For a full, detailed list, view our report

[Market trend]
• Presence of venture capitalists in market
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents

PART 01: Executive summary

PART 02: Scope of  the report

Market overview
Top-vendor offerings

PART 03: Market research methodology

Research methodology
Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Market landscape

Market overview
Market size and forecast
Five forces analysis

PART 06: Market segmentation by products

Instruments and imaging systems
Consumables and accessories

PART 07: Market segmentation by application

Breast cancer
Lung cancer
Colorectal cancer
Lymphoma
Cervical cancer
Prostate cancer
Other diseases

PART 08: Market segmentation by end-user

Hospitals
Clinical diagnostic laboratories
Physicians€™ office laboratories

PART 09: Geographical segmentation

Anatomic pathology testing market in Americas
Anatomic pathology testing market in EMEA
Anatomic pathology testing market in APAC

PART 10: Market drivers

Growing prevalence of cancer in demographics
Use of biomarkers for disease diagnosis and increasing efficiency
Paradigm shift toward precision diagnosis through personalized medicine

PART 11: Impact of drivers

PART 12: Market challenges

Insurance coverage and reimbursement issues
Limitations of closed systems
High initial investment and maintenance cost

PART 13: Impact of drivers and challenges

PART 14: Market trends

Presence of venture capitalists in market
Ready-to-use reagents
Business strategies to increase market competitiveness

PART 15: Vendor landscape

Competitive landscape analysis

PART 16: Key vendor analysis

Abbott Diagnostics
Agilent Technologies
Danaher
Roche Diagnostics
Thermo Fisher Scientific
Other prominent vendors

PART 17: Appendix

List of abbreviations

PART 18: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings

Exhibit 02: Methods used in anatomic pathology testing

Exhibit 03: Use of digital pathology testing

Exhibit 04: Global anatomic pathology testing market 2016-2021 ($ millions)

Exhibit 05: Product dynamic analysis of instruments and reagents in 2016 and 2021

Exhibit 06: Five forces analysis

Exhibit 07: Global anatomic pathology testing market by products in 2016 and 2021 ($ billions)

Exhibit 08: Market overview: Instruments and imaging systems

Exhibit 09: Anatomic pathology testing market by instruments and imaging systems 2016-2021 ($ billions)

Exhibit 10: Market overview: Consumables and accessories

Exhibit 11: Anatomic pathology testing market by consumables and accessories 2016-2021 ($millions)

Exhibit 12: Global anatomic pathology testing market by application in 2016

Exhibit 13: Global anatomic pathology testing market by end-users in 2015

Exhibit 14: Strategies, benefits and challenges of clinical diagnostic laboratories to remain competitive

Exhibit 15: Global anatomic pathology testing market by geography in 2016 and 2021 ($billions)

Exhibit 16: Market overview: Anatomic pathology testing market in Americas

Exhibit 17: Anatomic pathology testing market in Americas 2016-2021 ($ billions)

Exhibit 18: Key takeaway: Anatomic pathology testing market in US

Exhibit 19: PEST analysis: Anatomic pathology testing market in UK

Exhibit 20: Market overview: Anatomic pathology testing market in EMEA

Exhibit 21: Anatomic pathology testing market in EMEA 2016-2021 ($billions)

Exhibit 22: Key takeaway: Anatomic pathology testing market in UK

Exhibit 23: PEST analysis: Anatomic pathology testing market in UK

Exhibit 24: Market overview: Anatomic pathology testing market in APAC

Exhibit 25: Anatomic pathology testing market in APAC 2016-2021 ($billions)

Exhibit 26: Key takeaway: Anatomic pathology testing market in China

Exhibit 27: PEST analysis: Anatomic pathology testing market in China

Exhibit 28: People in age group 60 years and above worldwide 2010-2050

Exhibit 29: Companies and laboratories focusing on biomarkers

Exhibit 30: Companies focusing on companion diagnostic and personalized medicine

Exhibit 31: Impact of drivers

Exhibit 32: Impact of drivers and challenges

Exhibit 33: Partnership between companies and venture capitalists

Exhibit 34: Business strategies by companies to remain competitive in market

Exhibit 35: Competitive structure analysis of global anatomic pathology testing market 2015

Exhibit 36: Competitive analysis of global anatomic pathology testing market 2016

Exhibit 37: Abbott Diagnostics: Strength assessment

Exhibit 38: Abbott Diagnostics: Strategy assessment

Exhibit 39: Abbott Diagnostics: Opportunity assessment

Exhibit 40: Agilent Technologies: Strength assessment

Exhibit 41: Agilent Technologies: Strategy assessment

Exhibit 42: Agilent Technologies: Opportunity assessment

Exhibit 43: Danaher: Strength assessment

Exhibit 44: Danaher: Strategy assessment

Exhibit 45: Danaher: Opportunity assessment

Exhibit 46: Roche Diagnostics: Strength assessment

Exhibit 47: Roche Diagnostics: Strategy assessment

Exhibit 48: Roche Diagnostics: Opportunity assessment

Exhibit 49: Thermo Fisher Scientific: Strength assessment

Exhibit 50: Thermo Fisher Scientific: Strategy assessment

Exhibit 51: Thermo Fisher Scientific: Opportunity assessment

Exhibit 52: Other prominent vendors



【資料のキーワード】

病理解剖検査、病理検査、癌検査、疾患検査、病理解剖検査装置

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[病理解剖検査の世界市場2017-2021]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆